Subscribe
Subscribe
Picture of BioVox

BioVox

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is powered by Biovia: the health innovation cluster for Flanders.
Picture of BioVox

BioVox

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is powered by Biovia: the health innovation cluster for Flanders.

Aratana Therapeutics gets award for Best animal Company in North America 2016

Aratana Therapeutics, a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, won Animal Pharm's Best Company in North America 2016.

Protein found that drives allergic sensitivity in newborns

ULB elucidates part of brain construction process

New insights in genetic defect allow prevention of fatal illnesses in children

European patent attorney and biotech expert Caroline Pallard joins NLO patent office in Belgium

MDx Health ConfirMDx test covered by new insurance group

MDxHealth Announces Horizon Blue Cross Blue Shield of New Jersey Issues Positive Coverage Policy on ConfirmMDx. The decision provides access to more than 3.8 million members.

Medulloblastoma orphan drug designation for Oncurious

Market Access – the pitfall where innovations go lost

Market access is a crucial turning point for many companies. Getting your drug reimbursed by the government means the world. However, gaining market access [...]

Better together: R&D and GMP analytics teamed up at anaRIC Biologics

Coris Bioconcept diagnoses antibiotic resistance

With almost 20 years of experience, Coris BioConcept knows the world of infectious disease diagnostics inside and out. Their straightforward chromatography-based [...]

Legislators finally embrace in silico trials

In silico analysis is a natural complement to in vivo and in vitro testing. It uses engineering simulation to create reliable, computer-based models that predict [...]

PharmaFluidics raises 2.7 million euro to commercialize novel micro-chip device

PharmaFluidics NV, a game-changing innovator in the field of analytical chromatography, announced today that it has raised 2.7 million euro of additional funding.

Survivors’s plasma to treat ebola patients does not meet expectations

Ebola Tx is the largest clinical study ever performed with blood plasma of people that survived Ebola, to treat the disease. The study was performed in Guinea by the Institute of Tropical Medicine (ITM) in Antwerp. The results of the study, which took place in 2015 during the  Ebola epidemic, not only show that this treatment is feasible, but also that it presents no risk. The treatment causes very few side effects. However, the effectiveness needs to be further examined.

Ablynx initiates Phase IIb study of inhaled anti-RSV nanobody

ViroVet successfully raises €5 million in series A funding